Evidence map›Paper›PMID 29780610›Full record

ArticleMultiple sclerosis journal - experimental, translational and clinical

A randomised, controlled clinical trial of narrowband UVB phototherapy for clinically isolated syndrome: The PhoCIS study.

Prue H Hart, Anderson P Jones, Stephanie Trend, Lilian Cha, Marzena J Fabis-Pedrini, Matthew N Cooper, Catherine d'Este, Sian Geldenhuys, William M Carroll, Scott N Byrne and 4 more

Open access · goldAbstract read
In one paragraph

Article in Multiple sclerosis journal - experimental, translational and clinical. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Beneficial health effects of ultraviolet radiation: expert review and conference report.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2025
    Review
  5. Article
  6. Seasonal variation in sunlight exposure is differently associated with changes in T regulatory and T-helper 17 cell blood counts in adolescent and adults females: a pilot study.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2025
    Article
  7. Article
  8. The effects of exposure to solar radiation on human health.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severity.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  15. Review
  16. Insufficient Sun Exposure Has Become a Real Public Health Problem.International journal of environmental research and public health · 2020
    Review
  17. IgGClinical & translational immunology · 2020
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 1 country.

Prue H HartTelethon Kids Institute, University of Western Australia, Australia.ORCID 0000-0001-7207-6467
Anderson P JonesTelethon Kids Institute, University of Western Australia, Australia.
Stephanie TrendTelethon Kids Institute, University of Western Australia, Australia.ORCID 0000-0003-0210-3452
Lilian ChaTelethon Kids Institute, University of Western Australia, Australia.
Marzena J Fabis-PedriniCentre for Neuromuscular and Neurological Disorders, Perron Institute for Neurological and Translational Science, University of Western Australia, Sir Charles Gairdner Hospital, Australia.
Matthew N CooperTelethon Kids Institute, University of Western Australia, Australia.
Catherine d'EsteNational Centre for Epidemiology and Population Health, Research School of Population Health, Australian National University, Australia.
Sian GeldenhuysTelethon Kids Institute, University of Western Australia, Australia.
William M CarrollCentre for Neuromuscular and Neurological Disorders, Perron Institute for Neurological and Translational Science, University of Western Australia, Sir Charles Gairdner Hospital, Australia.
Scott N ByrneUniversity of Sydney, Sydney Medical School, Westmead Institute for Medical Research, Australia.
David R BoothUniversity of Sydney, Sydney Medical School, Westmead Institute for Medical Research, Australia.
Judith M ColeSt John of God Dermatology, Australia.
Robyn M LucasNational Centre for Epidemiology and Population Health, Research School of Population Health, Australian National University, Australia.
Allan G KermodeCentre for Neuromuscular and Neurological Disorders, Perron Institute for Neurological and Translational Science, University of Western Australia, Sir Charles Gairdner Hospital, Australia.
The Kids Research Institute Australia · AUAustralian National University · AUThe University of Sydney · AUThe University of Western Australia · AUMurdoch University · AUSt John of God Hospital · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe natural history of multiple sclerosis (MS) typically presents with the clinically isolated syndrome (CIS), an episode of neurological symptoms caused by central nervous system inflammation or demyelination that does not fulfil the diagnostic criteria for MS.

objectiveAs preclinical studies have suggested that exposure to ultraviolet radiation (UVR) could regulate the development of MS, the Phototherapy for CIS (PhoCIS trial) was established to examine the effects of narrowband UVB phototherapy on patients with CIS, and their conversion to MS.

methodsOf the 20 participants, half received 24 sessions of narrowband UVB exposure over eight weeks; participants in both arms were followed for 12 months. All participants were supplemented to 25-hydroxyvitamin D

resultsBy 12 months, 100% of those in the no phototherapy arm and 70% in the phototherapy arm had converted to MS, although this difference was not statistically significant.

conclusionThis study provides a basis for further studies to determine if there are any benefits of the therapeutic effects of narrowband UVB radiation on MS progression.

Indexed as

clinically isolated syndromeNarrowband UVB phototherapytrialUV-induced immunosuppressionvitamin D supplementation

Identifiers

PMID29780610
PMCPMC5954316
OpenAlexW2801930009

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.